A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE3

Conditions

Obstructive Hypertrophic Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing Municipality, China
Contact: Study coordinator (Lianming Kang) · lianmingkang@126.com · +86-010-88396870
Contact: Principal Investigator (Lianming Kang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

Beijing, China

A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Pediatric · Symptomatic Obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Los Angeles, United States

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Obstructive Cardiomyopathy, Hypertrophic · Non-obstructive Hypertrophic Cardiomyopathy

IsraelRecruitingPHASE3

Phoenix, United States · Scottsdale, United States

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States · Los Angeles, United States